Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the understanding and treatment of Cutaneous T-cell Lymphoma. | Front Oncol | 2022 | 36505788 | PubTator, text mining | PubMed |
| Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning. | Science | 2022 | 36480602 | PubTator, text mining | PubMed |
| Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD. | PLoS One | 2022 | 36480517 | PubTator, text mining | PubMed |
| Identification and exploration of novel M2 macrophage-related biomarkers in the development of acute myocardial infarction. | Front Cardiovasc Med | 2022 | 36440001 | PubTator, text mining | PubMed |
| Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4+ regulatory T cells. | Sci Rep | 2022 | 36434024 | PubTator, text mining | PubMed |
| 1,25(OH)2D3 Promotes Macrophage Efferocytosis Partly by Upregulating ASAP2 Transcription via the VDR-Bound Enhancer Region and ASAP2 May Affect Antiviral Immunity. | Nutrients | 2022 | 36432619 | PubTator, text mining | PubMed |
| Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs). | Int J Mol Sci | 2022 | 36430728 | PubTator, text mining | PubMed |
| Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma. | Cancers (Basel) | 2022 | 36428791 | PubTator, text mining | PubMed |
| Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland. | Biomedicines | 2022 | 36428480 | PubTator, text mining | PubMed |
| Genomic signatures of recent convergent transitions to social life in spiders. | Nat Commun | 2022 | 36414623 | PubTator, text mining | PubMed |
| B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer. | iScience | 2022 | 36388990 | PubTator, text mining | PubMed |
| Tetrabromobisphenol A effects on differentiating mouse embryonic stem cells reveals unexpected impact on immune system. | Front Genet | 2022 | 36386828 | PubTator, text mining | PubMed |
| Regulation of B cell receptor signalling by Epstein-Barr virus nuclear antigens. | Biochem J | 2022 | 36383217 | PubTator, text mining | PubMed |
| From structure to function - Ligand recognition by myeloid C-type lectin receptors. | Comput Struct Biotechnol J | 2022 | 36382179 | PubTator, text mining | PubMed |
| Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma. | Exp Mol Med | 2022 | 36380016 | PubTator, text mining | PubMed |
| Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell-mediated antitumor immunity. | J Clin Invest | 2022 | 36377656 | PubTator, text mining | PubMed |
| Costimulatory CD226 Signaling Regulates Proliferation of Memory-like NK Cells in Healthy Individuals with Latent Mycobacterium tuberculosis Infection. | Int J Mol Sci | 2022 | 36361628 | PubTator, text mining | PubMed |
| Keratinocyte-induced costimulation of human T cells through CD6 - but not CD2 - activates mTOR and prevents oxidative stress. | Front Immunol | 2022 | 36353616 | PubTator, text mining | PubMed |
Angioimmunoblastic T-cell lymphoma with extensive follicular dendritic cell and fibroblastic reticular cell network proliferation mimicking follicular dendritic cell sarcoma: A case report with pathologic, immunophenotypic, and molecular findings. | Front Oncol | 2022 | 36353546 | PubTator, text mining | PubMed |
| Inflammatory signaling on cytochrome P450-mediated drug metabolism in hepatocytes. | Front Pharmacol | 2022 | 36353494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=18